keyword
MENU ▼
Read by QxMD icon Read
search

H3 antagonist

keyword
https://read.qxmd.com/read/30742585/effect-of-the-fexofenadine-on-the-expression-of-hrh-1-and-hrh-4-receptor-in-peripheral-blood-mononuclear-cell-isolated-from-children-with-diagnosed-allergy-in-vitro-study-short-communication
#1
Natalia Kordulewska, Anna Cieślińska, Ewa Fiedorowicz, Beata Jarmołowska, Elżbieta Kostyra
PURPOSE: Fexofenadine (FXF) is the active metabolite of terfenadine with selective peripheral H1 receptor antagonist activity. FXF is a third-generation antihistamine, non-sedating, rapid and very long acting used in symptoms associated with allergic diseases such as allergic rhinitis, asthma and dermatitis. The pleiotropic effects of histamine are mediated by four types of receptors that belong to the G-protein-coupled receptor family: histamine H1 receptor (HRH-1), histamine H2 receptor, histamine H3 receptor, and histamine H4 receptor...
2019: Journal of Pharmacy & Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences
https://read.qxmd.com/read/30710752/epigenetic-demthylation-of-sfrps-with-emphasis-on-sfrp4-activation-leading-to-wnt-signaling-suppression-and-histone-modifications-in-breast-prostate-and-ovary-cancer-stem-cells
#2
Abhijeet Deshmukh, Frank Arfuso, Philip Newsholme, Arun Dharmarajan
The expression and levels of secreted frizzled-related proteins (sFRPs), important Wnt signalling antagonists, have been reported to be reduced in various cancers, and are associated with disease progression and poor prognosis. During tumour development, all sFRP (1, 2, 3, 4, and 5) genes are hypermethylated, causing transcriptional silencing. sFRPs have an ability to sensitize tumour cells to chemotherapeutic drugs, enhancing cell death. Reduced Wnt signalling is associated with loss of cancer stem cell (CSC) viability...
January 30, 2019: International Journal of Biochemistry & Cell Biology
https://read.qxmd.com/read/30710391/central-nervous-system-effects-of-the-histamine-3-receptor-antagonist-cep-26401-in-comparison-with-modafinil-and-donepezil-after-a-single-dose-in-a-cross-over-study-in-healthy-volunteers
#3
A C Baakman, R Zuiker, J M A van Gerven, N Gross, R Yang, M Fetell, A Gershon, Y Gilgun-Sherki, E Hellriegel, O Spiegelstein
AIMS: In previous studies, the H3 R antagonist CEP-26401 had a subtle effect on spatial working memory, with the best effect seen at the lowest dose tested (20μg), and a dose-dependent disruption of sleep. In the current study, three low dose levels of CEP-26401 were compared with modafinil and donepezil. METHODS: In this double-blind, placebo- and positive-controlled, randomized, partial six-way cross-over study, 40 healthy subjects received single doses of placebo, CEP-26401 (5, 25, or 125 μg) or modafinil 200mg or donepezil 10mg...
February 2, 2019: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/30658039/communication-between-the-ligand-binding-pocket-lbp-and-the-activation-function-2-af2-domain-of-androgen-receptor-revealed-by-molecular-dynamics-simulations
#4
Ye Jin, Mojie Duan, Xuwen Wang, Xiaotian Kong, Wenfang Zhou, Huiyong Sun, Hui Liu, Dan Li, Huidong Yu, Youyong Li, Tingjun Hou
Androgen receptor (AR), as a member of the nuclear receptor (NR) superfamily, regulates the gene transcription in response to the sequential binding of diverse agonists and coactivators. Great progress has been made in the studies on the pharmacology and structure of AR, but the atomic level mechanism of the bidirectional communications between the ligand-binding pocket (LBP) and the activation function-2 (AF2) region of AR remains poorly understood. Therefore, in this study, molecular dynamics (MD) simulations and free energy calculations were carried out to explore the interactions among water, agonist (DHT) or antagonist (HFT), AR and coactivator (SRC3)...
January 18, 2019: Journal of Chemical Information and Modeling
https://read.qxmd.com/read/30654600/expression-of-histidine-decarboxylase-and-its-roles-in-inflammation
#5
REVIEW
Noriyasu Hirasawa
Histamine is a well-known mediator of inflammation that is released from mast cells and basophils. To date, many studies using histamine receptor antagonists have shown that histamine acts through four types of receptors: H1, H2, H3, and H4. Thus, histamine plays more roles in various diseases than had been predicted. However, our knowledge about histamine-producing cells and the molecular mechanisms underlying histamine production at inflammatory sites is still incomplete. The histamine producing enzyme, histidine decarboxylase (HDC), is commonly induced at inflammatory sites during the late and chronic phases of both allergic and non-allergic inflammation...
January 16, 2019: International Journal of Molecular Sciences
https://read.qxmd.com/read/30641102/single-chain-peptide-agonists-of-relaxin-receptors
#6
REVIEW
Praveen Praveen, Martina Kocan, Adam Valkovic, Ross Bathgate, Mohammed Akhter Hossain
There are seven human relaxin family peptides that have two chains (A and B) and three disulfide bonds. The target receptors for four of these peptides are known as relaxin family peptide receptors, RXFP1-RXFP4. Detailed structure-activity relationship (SAR) studies of relaxin family peptides have been reported over the years and have led to the design of new analogs with agonistic and antagonistic properties. This review briefly summarizes the SAR of human relaxin 2 (H2 relaxin) and human relaxin 3 (H3 relaxin) leading to the design and development of single-B-chain only agonists, B7-33 and peptide 5...
January 11, 2019: Molecular and Cellular Endocrinology
https://read.qxmd.com/read/30604761/a-chemical-biology-toolbox-to-study-protein-methyltransferases-and-epigenetic-signaling
#7
Sebastian Scheer, Suzanne Ackloo, Tiago S Medina, Matthieu Schapira, Fengling Li, Jennifer A Ward, Andrew M Lewis, Jeffrey P Northrop, Paul L Richardson, H Ümit Kaniskan, Yudao Shen, Jing Liu, David Smil, David McLeod, Carlos A Zepeda-Velazquez, Minkui Luo, Jian Jin, Dalia Barsyte-Lovejoy, Kilian V M Huber, Daniel D De Carvalho, Masoud Vedadi, Colby Zaph, Peter J Brown, Cheryl H Arrowsmith
Protein methyltransferases (PMTs) comprise a major class of epigenetic regulatory enzymes with therapeutic relevance. Here we present a collection of chemical probes and associated reagents and data to elucidate the function of human and murine PMTs in cellular studies. Our collection provides inhibitors and antagonists that together modulate most of the key regulatory methylation marks on histones H3 and H4, providing an important resource for modulating cellular epigenomes. We describe a comprehensive and comparative characterization of the probe collection with respect to their potency, selectivity, and mode of inhibition...
January 3, 2019: Nature Communications
https://read.qxmd.com/read/30604198/cerebrospinal-inflammatory-response-following-scorpion-envenomation-role-of-histamine-h1-and-h3-receptors
#8
Amal Megdad-Lamraoui, Sonia Adi-Bessalem, Fatima Laraba-Djebari
BACKGROUND: The mechanism of the inflammatory process induced by scorpion venom in the cerebrospinal tissues has not yet been completely elucidated. Therefore, we aimed to investigate the role of histamine through its H1 and H3 receptors in this process. METHODS: Histamine H1 and H3 receptor antagonists, Hydroxyzine (10 mg/kg) and Betaserc (20 mg/kg), respectively, were administered by intraperitoneal route to mice 1 h before subcutaneous envenomation with a subletal dose (0...
January 2, 2019: Inflammopharmacology
https://read.qxmd.com/read/30582583/purification-of-h3-and-h4-histone-proteins-and-the-quantification-of-acetylated-histone-marks-in-cells-and-brain-tissue
#9
Karolina J Janczura, Claude-Henry Volmar, Claes Wahlestedt
In all eukaryotic organisms, chromatin, the physiological template of all genetic information, is essential for heredity. Chromatin is subject to an array of diverse posttranslational modifications (PTMs) that mostly occur in the amino termini of histone proteins (i.e., histone tail) and regulate the accessibility and functional state of the underlying DNA. Histone tails extend from the core of the nucleosome and are subject to the addition of acetyl groups by histone acetyltransferases (HATs) and the removal of acetyl groups by histone deacetylases (HDACs) during cellular growth and differentiation...
November 30, 2018: Journal of Visualized Experiments: JoVE
https://read.qxmd.com/read/30577532/extracellular-histones-activate-plasma-membrane-toll-like-receptor-9-to-trigger-calcium-oscillations-in-rat-pancreatic-acinar-tumor-cell-ar4-2j
#10
Hai Yan Guo, Zong Jie Cui
In acute pancreatitis, histones are released by infiltrating neutrophils, but how histones modulate pancreatic acinar cell function has not been investigated. We have examined histone modulation of rat pancreatic acini and pancreatic acinar tumor cell AR4-2J by calcium imaging. Histones were found to have no effect on calcium in pancreatic acini but blocked calcium oscillations induced by cholecystokinin or acetylcholine. Both mixed (Hx) and individual (H1, H2A, H2B, H3, H4) histones induced calcium oscillations in AR4-2J...
December 20, 2018: Cells
https://read.qxmd.com/read/30557779/impact-of-moderate-prenatal-alcohol-exposure-on-histaminergic-neurons-histidine-decarboxylase-levels-and-histamine-h-2-receptors-in-adult-rat-offspring
#11
Suzy Davies, Carmen Ballesteros-Merino, Nyika A Allen, Morgan W Porch, Morgan E Pruitt, Kyle H Christensen, Martina J Rosenberg, Daniel D Savage
We have reported that moderate prenatal alcohol exposure (PAE) elevates histamine H3 receptor-mediated inhibition of glutamatergic neurotransmission in dentate gyrus (DG), and that the H3 receptor antagonist ABT-239 ameliorates PAE-induced deficits in DG long-term potentiation. Here, we investigated whether PAE alters other markers of histaminergic neurotransmission. Long-Evans rat dams voluntarily consumed either a 0% or a 5% ethanol solution 4 h each day throughout gestation. Young adult female offspring from each prenatal treatment group were used in histidine decarboxylase (HDC) immunohistochemical studies of histamine neuron number in ventral hypothalamus, quantitative Western blotting studies of HDC expression in multiple brain regions, radiohistochemical studies of H2 receptor density in multiple brain regions, and in biochemical studies of H2 receptor-effector coupling in dentate gyrus...
July 22, 2018: Alcohol
https://read.qxmd.com/read/30536350/histamine-h3-receptor-antagonist-clobenpropit-protects-propofol-induced-apoptosis-of-hippocampal-neurons-through-pi3k-akt-pathway
#12
W He, Q-H Yuan, Q Zhou
OBJECTIVE: The aim of the study was to explore whether histamine H3 receptor antagonist Clobenpropit could protect propofol-induced neurotoxicity in hippocampal neurons. MATERIALS AND METHODS: Hippocampal neurons were extracted from neonatal rats and induced with propofol. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay was performed to detect apoptotic rate of neurons. Western blot was conducted to detect protein levels of cleaved-caspase-3 and Bax/Bcl2...
November 2018: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/30517868/polycomb-and-methylation-independent-roles-of-ezh2-as-a-transcription-activator
#13
Jung Kim, Yongik Lee, Xiaodong Lu, Bing Song, Ka-Wing Fong, Qi Cao, Jonathan D Licht, Jonathan C Zhao, Jindan Yu
Enhancer of Zeste 2 (EZH2) is the enzymatic subunit of Polycomb Repressive Complex 2 (PRC2), which catalyzes histone H3 lysine 27 trimethylation (H3K27me3) at target promoters for gene silencing. Here, we report that EZH2 activates androgen receptor (AR) gene transcription through direct occupancy at its promoter. Importantly, this activating role of EZH2 is independent of PRC2 and its methyltransferase activities. Genome-wide assays revealed extensive EZH2 occupancy at promoters marked by either H3K27ac or H3K27me3, leading to gene activation or repression, respectively...
December 4, 2018: Cell Reports
https://read.qxmd.com/read/30503715/neurobiological-and-immunogenetic-aspects-of-narcolepsy-implications-for-pharmacotherapy
#14
REVIEW
Steven T Szabo, Michael J Thorpy, Geert Mayer, John H Peever, Thomas S Kilduff
Excessive daytime sleepiness (EDS) and cataplexy are common symptoms of narcolepsy, a sleep disorder associated with the loss of hypocretin/orexin (Hcrt) neurons. Although only a few drugs have received regulatory approval for narcolepsy to date, treatment involves diverse medications that affect multiple biochemical targets and neural circuits. Clinical trials have demonstrated efficacy for the following classes of drugs as narcolepsy treatments: alerting medications (amphetamine, methylphenidate, modafinil/armodafinil, solriamfetol [JZP-110]), antidepressants (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors), sodium oxybate, and the H3 -receptor inverse agonist/antagonist pitolisant...
February 2019: Sleep Medicine Reviews
https://read.qxmd.com/read/30498275/report-from-a-consensus-conference-on-the-treatment-of-m%C3%A3-ni%C3%A3-re-s-disease-with-betahistine-rationale-methodology-and-results
#15
A P Casani, G Guidetti, R Schoenhuber
Ménière's disease is a disorder of the inner ear that causes vertigo, tinnitus, fullness and hearing loss. Although several treatments are available, the success rate is reported to be around 70%, similar to placebo. Betahistine, a weak H1 receptor agonist and an effective H3 receptor antagonist, is frequently prescribed for Ménière's disease, especially to reduce recurrent vertigo attacks. The effects of this drug on hearing and other audiological symptoms remains unclear. Given the inconclusive reports in the literature, we proposed a consensus conference on the use of betahistine in Ménière's disease...
October 2018: Acta Otorhinolaryngologica Italica
https://read.qxmd.com/read/30402543/multiple-modes-of-prc2-inhibition-elicit-global-chromatin-alterations-in-h3k27m-pediatric-glioma
#16
James M Stafford, Chul-Hwan Lee, Philipp Voigt, Nicolas Descostes, Ricardo Saldaña-Meyer, Jia-Ray Yu, Gary Leroy, Ozgur Oksuz, Jessica R Chapman, Fernando Suarez, Aram S Modrek, N Sumru Bayin, Dimitris G Placantonakis, Matthias A Karajannis, Matija Snuderl, Beatrix Ueberheide, Danny Reinberg
A methionine substitution at lysine-27 on histone H3 variants (H3K27M) characterizes ~80% of diffuse intrinsic pontine gliomas (DIPG) and inhibits polycomb repressive complex 2 (PRC2) in a dominant-negative fashion. Yet, the mechanisms for this inhibition and abnormal epigenomic landscape have not been resolved. Using quantitative proteomics, we discovered that robust PRC2 inhibition requires levels of H3K27M greatly exceeding those of PRC2, seen in DIPG. While PRC2 inhibition requires interaction with H3K27M, we found that this interaction on chromatin is transient, with PRC2 largely being released from H3K27M...
October 2018: Science Advances
https://read.qxmd.com/read/30385161/design-and-synthesis-of-histamine-h-3-h-4-receptor-ligands-with-a-cyclopropane-scaffold
#17
Mizuki Watanabe, Takaaki Kobayashi, Yoshihiko Ito, Hayato Fukuda, Shizuo Yamada, Mitsuhiro Arisawa, Satoshi Shuto
We previously designed and synthesized a series of histamine analogues with an imidazolylcyclopropane scaffold and identified potent non-selective antagonists for histamine H3 and H4 receptor subtypes. In this study, to develop H4 selective ligands, we newly designed and synthesized cyclopropane-based derivatives having an indole, benzimidazole, or piperazine structure, which are components of representative H4 selective antagonists such as JNJ7777120 and JNJ10191584. Among the synthesized derivatives, imidazolylcyclopropanes 12 and 13 conjugated with a benzimidazole showed binding affinity to the H3 and H4 receptors comparable to that of a well-known non-selective H3 /H4 antagonist, thioperamide...
October 26, 2018: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/30380674/studies-on-anticonvulsant-effects-of-novel-histamine-h3r-antagonists-in-electrically-and-chemically-induced-seizures-in-rats
#18
Alaa Alachkar, Dorota Łażewska, Gniewomir Latacz, Annika Frank, Agata Siwek, Annamaria Lubelska, Ewelina Honkisz-Orzechowska, Jadwiga Handzlik, Holger Stark, Katarzyna Kieć-Kononowicz, Bassem Sadek
A newly developed series of non-imidazole histamine H3 receptor (H3R) antagonists ( 1 ⁻ 16 ) was evaluated in vivo for anticonvulsant effects in three different seizure models in Wistar rats. Among the novel H3R antagonists examined, H3R antagonist 4 shortened the duration of tonic hind limb extension (THLE) in a dose-dependent fashion in the maximal electroshock (MES)-induced seizure and offered full protection against pentylenetetrazole (PTZ)-induced generalized tonic-clonic seizure (GTCS), following acute systemic administration (2...
October 29, 2018: International Journal of Molecular Sciences
https://read.qxmd.com/read/30359671/decreased-h3k9ac-level-of-at2r-mediates-the-developmental-origin-of-glomerulosclerosis-induced-by-prenatal-dexamethasone-exposure-in-male-offspring-rats
#19
Bin Li, Yanan Zhu, Haiyun Chen, Hui Gao, Hangyuan He, Na Zuo, Linguo Pei, Wen Xie, Liaobin Chen, Ying Ao, Hui Wang
This study aimed to demonstrate that prenatal dexamethasone exposure (PDE) can induce kidney dysplasia in utero and adult glomerulosclerosis in male offspring, and to explore the underlying intrauterine programming mechanisms. Pregnant rats were subcutaneously administered dexamethasone 0.2 mg/kg.d from gestational day (GD) 9 to GD20. The male fetus on GD20 and the adult offspring at age of postnatal week 28 were analyzed. The adult offspring kidneys in the PDE group displayed glomerulosclerosis, elevated levels of serum creatinine and urine protein, ultrastructural damage of podocytes, the reduced expression levels of podocyte marker genes, nephrin and podocin...
October 22, 2018: Toxicology
https://read.qxmd.com/read/30359639/drug-receptor-kinetics-and-sigma-1-receptor-affinity-differentiate-clinically-evaluated-histamine-h-3-receptor-antagonists
#20
Darren M Riddy, Anna E Cook, David M Shackleford, Tracie L Pierce, Elisabeth Mocaer, Clotilde Mannoury la Cour, Aurore Sors, William N Charman, Roger J Summers, Patrick M Sexton, Arthur Christopoulos, Christopher J Langmead
The histamine H3 receptor is a G protein-coupled receptor (GPCR) drug target that is highly expressed in the CNS, where it acts as both an auto- and hetero-receptor to regulate neurotransmission. As such, it has been considered as a relevant target in disorders as varied as Alzheimer's disease, schizophrenia, neuropathic pain and attention deficit hyperactivity disorder. A range of competitive antagonists/inverse agonists have progressed into clinical development, with pitolisant approved for the treatment of narcolepsy...
October 22, 2018: Neuropharmacology
keyword
keyword
159984
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"